Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Rotavirus
2021
Africa
Europe
Clear all
Type of publications
NITAG documentation
(93)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Africa
(20)
Europe
(77)
Americas
(66)
South-East Asia
(2)
Western Pacific
(14)
Countries
Belgium
(15)
Burkina Faso
(1)
Denmark
(1)
France
(16)
Germany
(8)
Ireland
(7)
Netherlands
(7)
Nigeria
(1)
Senegal
(3)
South Africa
(1)
Spain
(1)
Sweden
(2)
Uganda
(13)
United Kingdom
(19)
Diseases
COVID-19
(93)
Rotavirus
(4)
Hepatitis B
(2)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(3)
Influenza
(4)
Malaria
(1)
Pneumococcal disease
(1)
Poliomyelitis
(2)
Tetanus
(2)
Varicella
(1)
Vaccine topics
Acceptance
(2)
Coverage
(2)
Efficacy/effectiveness
(1)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(3)
All age groups
(1)
Children
(1)
Newborn
(1)
Older adults
(1)
Pregnant women
(1)
Risk group
(2)
Publication date
2021
(97)
2024
(1)
2023
(22)
2022
(59)
2020
(20)
2019
(1)
2018
(1)
2017
(4)
2016
(5)
2015
(3)
2014
(1)
2013
(2)
2012
(1)
2010
(2)
2009
(1)
2006
(3)
97 results found
2021
∙
STIKO
STIKO resolution on the 8th update of the COVID-19 vaccination recommendation and the associated scientific justification - 8 July 2021
2021
∙
STIKO
STIKO statement on the time of administration of an mRNA vaccine after first vaccination with AstraZeneca Vaccine (Vaxzevria) in <60-year-olds - 14 April, 2021
2021
∙
UNITAG
The Significance of COVID-19 Vaccination Prioritisation to the Safe Re-Opening and Management of Schools in Uganda
2021
∙
UNITAG
UNITAG Advisory to the Ministry of Health on the status of Post Vaccine COVID-19 Infections and Breakthrough cases in Uganda
2021
∙
UNITAG
UNITAG Interim Recommendation on COVID-19 Vaccine Allocation and Prioritisation
2021
∙
UNITAG
UNITAG Recommendation on the Choice of COVID-19 Vaccines for Uganda
2021
∙
UNITAG
UNITAG Updated Recommendation on Pfizer-BioNTech vaccine
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2021
∙
JCVI
Update to JCVI advice on booster vaccination in adults
2021
∙
NIAC
Updated recommendations regarding selection, dose and timing of booster doses of COVID-19 vaccine for those aged 60 years and over
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register